Zehbe I - Search Results

1

Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant.

Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I. Grodzki M, et al. Among authors: zehbe i. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):820-2. doi: 10.1158/1055-9965.EPI-05-0864. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16614130

2

Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.

Zehbe I, Mytilineos J, Wikström I, Henriksen R, Edler L, Tommasino M. Zehbe I, et al. Hum Immunol. 2003 May;64(5):538-42. doi: 10.1016/s0198-8859(03)00033-8. Hum Immunol. 2003. PMID: 12691704

3

Activities of human papillomavirus 16 E6 natural variants in human keratinocytes.

Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, Tommasino M, Zehbe I, Sherman L. Asadurian Y, et al. Among authors: zehbe i. J Med Virol. 2007 Nov;79(11):1751-60. doi: 10.1002/jmv.20978. J Med Virol. 2007. PMID: 17854024

4

Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential.

Zehbe I, Lichtig H, Westerback A, Lambert PF, Tommasino M, Sherman L. Zehbe I, et al. Mol Cancer. 2011 Jun 24;10:77. doi: 10.1186/1476-4598-10-77. Mol Cancer. 2011. PMID: 21702904 Free PMC article.

5

Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype.

Zehbe I, Wilander E, Delius H, Tommasino M. Zehbe I, et al. Cancer Res. 1998 Feb 15;58(4):829-33. Cancer Res. 1998. PMID: 9485042

6

p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.

Zehbe I, Voglino G, Wilander E, Delius H, Marongiu A, Edler L, Klimek F, Andersson S, Tommasino M. Zehbe I, et al. Cancer Res. 2001 Jan 15;61(2):608-11. Cancer Res. 2001. PMID: 11212257

7

Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes.

Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E, Tommasino M. Zehbe I, et al. Int J Cancer. 2001 Dec 1;94(5):711-6. doi: 10.1002/ijc.1520. Int J Cancer. 2001. PMID: 11745467

8

Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.

Kämmer C, Tommasino M, Syrjänen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I. Kämmer C, et al. Among authors: zehbe i. Br J Cancer. 2002 Jan 21;86(2):269-73. doi: 10.1038/sj.bjc.6600024. Br J Cancer. 2002. PMID: 11870518 Free PMC article.

9

Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression.

Lee K, Magalhaes I, Clavel C, Briolat J, Birembaut P, Tommasino M, Zehbe I. Lee K, et al. Among authors: zehbe i. Virus Res. 2008 Jan;131(1):106-10. doi: 10.1016/j.virusres.2007.08.003. Epub 2007 Sep 14. Virus Res. 2008. PMID: 17869365

10

The role of TP53 in Cervical carcinogenesis.

Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, Zehbe I. Tommasino M, et al. Among authors: zehbe i. Hum Mutat. 2003 Mar;21(3):307-12. doi: 10.1002/humu.10178. Hum Mutat. 2003. PMID: 12619117 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters